Physician

David A Edmondson, DO

According to 2025 Medicare claims, David Edmondson, DO (NPI: 1124079033) practices allergy/immunology in the Wausau, WI market, with the plurality of this provider's patient population coming from Marathon, WI. This provider's primary affiliated billing organization is ENT & ALLERGY ASSOCIATES, S.C. (NPI: 1255384301; TIN: 391133811) and primary practice location at 54401-4147.

Edmondson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 261 traditional Medicare patients, billed 12,020 HCPCS/CPT codes, and received $278,033 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,480 prescription claims across 366 beneficiaries totaling $594,908 in drug costs, led by Dupixent Pen (Dupilumab). DME data shows 132 claims. Open Payments data shows 52 records totaling $51,294. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $35,595 to $278,033. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $90,495 to $594,908. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	139	2,753	$35,595
2016	168	3,640	$45,234
2017	176	3,877	$47,428
2018	208	4,776	$73,417
2019	254	7,928	$163,123
2020	255	7,632	$160,948
2021	260	7,295	$174,466
2022	260	9,527	$231,453
2023	240	12,256	$256,850
2024	261	12,020	$278,033

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	126	952	$90,495
2016	168	978	$98,810
2017	181	1,089	$178,789
2018	199	1,305	$359,108
2019	244	1,582	$466,024
2020	299	1,964	$539,935
2021	303	1,955	$550,447
2022	309	1,941	$589,017
2023	335	2,086	$666,534
2024	366	2,480	$594,908

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	89	$152,875
2016	N/R	149	$270,914
2017	N/R	152	$218,693
2018	N/R	160	$173,392
2019	N/R	150	$198,428
2020	N/R	115	$94,371
2021	N/R	119	$170,167
2022	N/R	148	$207,232
2023	N/R	117	$195,344
2024	N/R	132	$206,721

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	112	137	$81
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	53	53	$79
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	76	84	$59
94010	Test to measure expiratory airflow and volume	58	59	$16
95004	Test for allergy using allergenic extract	64	2,361	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Dupixent Pen	Dupilumab	20	784	$106,229
Dupixent Syringe	Dupilumab	27	756	$101,582
Breo Ellipta	Fluticasone/Vilanterol	127	4,680	$60,681
Advair Hfa	Fluticasone Propion/Salmeterol	105	3,570	$36,535
Xolair	Omalizumab	19	532	$33,944

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	N	N/R	36	$110,407
J1559	Injection, immune globulin (hizentra), 100 mg	N	N/R	20	$93,723
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	32	$1,826
A4222	Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)	N	N/R	12	$436
K0552	Supplies for external non-insulin drug infusion pump, syringe type cartridge, sterile, each	N	N/R	32	$328

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	52	$51,294	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for David A. Edmondson, DO?

Tedicare shows public-source Medicare data for David A. Edmondson, DO (NPI 1124079033), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David A. Edmondson, DO have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to David A. Edmondson, DO?

David A. Edmondson, DO is linked to ENT & ALLERGY ASSOCIATES, S.C. (billing NPI 1255384301) in the available physician profile data.

Does David A. Edmondson, DO have Open Payments data?

David A. Edmondson, DO has 52 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.